Survey Finds Ways for Oligo Suppliers to Differentiate Themselves

27-Apr-2004 - Arlington, VA. According to a recent survey, the overwhelming majority (91%) of scientific customers have not changed their primary supplier of custom synthetic oligonucleotides (oligos) over the past 12 months. Despite this fact, the customers of market leaders Integrated DNA Technologies, ...

Genzyme Celebrates Opening of New Global Headquarters

One of the Most Environmentally Responsible Office Buildings in United States

26-Apr-2004 - Cambridge, Mass. - Genzyme Corp. celebrated the opening of its new global headquarters, Genzyme Center, an innovative building that combines bold design and sophisticated technology to create an attractive and highly functional workplace for over 900 employees. The grand opening was held during ...

Ceres Obtains Commercial License From Japan Tobacco

23-Apr-2004 - Los Angeles. Ceres, Inc., a leading biotechnology company developing high value plants and plant-based products to benefit human health and agriculture has obtained a commercial license from Japan Tobacco Inc. for a proprietary transformation system known as PureIntro(TM). Terms of the agreement ...

Campus Vienna Biocenter - Architecture & Agency aid Scientific Communication

23-Apr-2004 - Vienna, the Biotech hub of Eastern and Central Europe, will see a significant extension. Today, a new laboratory-cum-office building is officially inaugurated. With its open architecture, the modern building stands for both internal and external scientific communication. Besides several research ...

Purely Proteins and Inhibox Launch Combined Drug Screening Programs

23-Apr-2004 - Cambridge, England. Purely Proteins Ltd (Cambridge, UK) and Inhibox Ltd (Oxford, UK) announced the launch of commercial drug discovery services based on their combined proprietary computational and laboratory-based screening technologies. This platform is commencing with the immediate launch of ...

Trinity Biotech Completes Acquisition of Fitzgerald Industries International

22-Apr-2004 - Dublin, Ireland. Trinity Biotech plc announced that it has completed the acquisition of Fitzgerald Industries International, Inc. Trinity Biotech has acquired the business of Fitzgerald for US$16 million consisting of cash of US$8 million and shares in Trinity Biotech of US$8 million. Fitzgerald ...

University of Ulster Opens Nanotechnology Research Institute

22-Apr-2004 - Belfast, Northern Ireland. The University of Ulster opened a new Nanotechnology Research Institute at its Jordanstown campus in Northern Ireland The GBP8m research institute will position Northern Ireland at the forefront of nanotechnology research in the UK, and will be a catalyst for the future ...

University of Rochester's Microarray Core Facility to Implement Ovation(TM) System as Standard RNA Amplification System

Facility to Utilize Ovation System Across Multiple Gene Expression Analysis Platforms

22-Apr-2004 - San Carlos, Calif. - NuGEN(TM) Technologies, Inc., a privately held company developing and commercializing the new standard in nucleic acid amplification and labeling systems, today announced that the University of Rochester will begin using its Ovation(TM) system as the standard RNA ...

Northeastern University Launches Multi-Track Professional Master of Science Degree Program in Biotechnology

University's Professional Science Master Programs Funded by the Alfred P. Sloan Foundation

21-Apr-2004 - Boston. Northeastern University's Professional Master of Science program in Bioinformatics, which was successfully launched in the Fall of 2001, has spawned a new interdisciplinary Professional Master of Science Degree program in Biotechnology, with specializations in molecular, pharmaceutical ...

CytRx Receives Milestone Payment From Vical for TranzFect Technology

21-Apr-2004 - Los Angeles. CytRx Corporation announced that it has received a $100,000 milestone payment due from Vical Incorporated pursuant to Vical's license of CytRx's TranzFect technology. CytRx's TranzFect technology is incorporated in a plasmid DNA vaccine for cytomegalovirus (CMV), being developed by ...